| Literature DB >> 21855138 |
Yiming Lin1, Randy A Hall, Michael J Kuhar.
Abstract
CART peptides are peptide neurotransmitters and hormones that are involved in many different physiological responses. While much is knownpan> about the peptides regarding their structure, processing and gene regulation, less is knownpan> about their postsynaptic actions and receptors. Using (125)I-CART 61-102 as a ligand and unlabeled CART 61-102 or CART 55-102 as displacers, high-affinity specific binding was detected in PC12 cells. Differentiation of the PC12 cells increased specific binding several-fold. The increase in specific binding found after differentiation was inhibited by actinomycin D and cycloheximide, suggesting that the increase in specific binding was dependent on RNA and protein synthesis. CART 1-27, a peptide that has never been shown to elicit responses, did not displace (125)I-CART 61-102 binding, nor did more than 20 other peptides that were examined. Surprisingly, however, PACAP 1-38 and PACAP 6-38 were found to be low-affinity inhibitors of CART binding. CART treatment increased binding of (35)S-GTPgamma-S to PC12 cell membranes. Moreover, CART treatment of intact PC12 cells elicited robust increases in phospho-ERK in a manner that was increased with differentiation, blocked by pertussis toxin and antagonized by PACAP 6-38. These findings extend previous research and suggest that the CART binding site in PC12 cells reflects a G protein-coupled receptor linked with Gi/o, and also demonstrate that PACAP 6-38 may be useful as a CART receptor antagonist.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21855138 PMCID: PMC3170513 DOI: 10.1016/j.npep.2011.07.006
Source DB: PubMed Journal: Neuropeptides ISSN: 0143-4179 Impact factor: 3.286